Skip to content
Taxonomy
CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery
Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to Read More
CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants
An international team of researchers from the Inherited Neuropathies Consortium Read More
CMTA Announces Its First Center of Excellence in Scotland
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B
CMTA is proud to share that research led by CMTA Read More
Accelerating Genetic Therapy for CMT4B1: A CMTA Research Update
With CMTA’s support, researchers at San Raffaele Scientific Institute in Read More
CMTA’s $300K Investment in CRISPR for CMT2A
The Charcot-Marie-Tooth Association (CMTA) is investing $300,000 in a groundbreaking Read More
What’s New in CMT Research and Care? A 2025 Update Published by CMTA-STAR Advisory Board Member Davide Pareyson, MD
CMTA Strategy To Accelerate Research (CMTA-STAR) Advisory Board member and Read More
CMTA Announces New Center of Excellence at UPMC in Pittsburgh, Pennsylvania
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA Fuels Breakthrough Imaging Research to Address CMT2A’s Cellular Weakness
The Charcot-Marie-Tooth Association (CMTA) announces a $90,860 investment in a Read More
Episode 3 of the Simply CMT Podcast with Dr. Katherine Forsey
Join us as we talk with Dr. Katherine Forsey, CMTA’s Read More
